Avoro Capital Advisors LLC lifted its position in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX – Free Report) by 13.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 13,050,000 shares of the biotechnology company’s stock after purchasing an additional 1,500,000 shares during […]